Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8744728 | Clinical Microbiology and Infection | 2018 | 25 Pages |
Abstract
eCDAs are valuable tools that have the potential to improve management of febrile children in primary care and increase the rational use of diagnostics and antimicrobials. Next steps in the evidence pathway should be larger effectiveness and impact studies (including cost analysis) and continuous integration of clinically useful diagnostic and treatment innovations.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
Kristina Keitel, Valérie D'Acremont,